Stockscreener 앱 받기
15.42
0.85%
0.13
시간 외 거래:
15.57
0.15
+0.97%
전일 마감가:
$15.29
열려 있는:
$15.16
하루 거래량:
651.31K
Relative Volume:
1.51
시가총액:
$476.89M
수익:
$72.35M
순이익/손실:
$-45.34M
주가수익비율:
-9.8185
EPS:
-1.5705
순현금흐름:
$-32.43M
1주 성능:
+14.99%
1개월 성능:
+34.20%
6개월 성능:
+230.19%
1년 성능:
+289.39%
1일 변동 폭
$15.00
$15.68
1주일 범위
$12.70
$15.68
52주 변동 폭
$3.22
$15.68
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
15.42 | 476.89M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2026-05-15 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-03-05 | 개시 | Northland Capital | Outperform |
| 2025-11-20 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2025-08-08 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
Avita Medical Inc. Reports 3,994,555 Net Reduction in CDIs on Issue for September 2026 - Kalkine
Avita Medical Inc. Notifies ASX of Unquoted Option Conversions Into Common Stock - Kalkine
AVITA Medical Director Dr. Michael Tarnoff Receives RSU Vesting Into Common Stock - Kalkine
AVITA Medical Director Dr. Michael Tarnoff Converts 8,750 RSUs into Common Shares - Kalkine Media
AVITA Medical, Inc. (AVH.AX) Stock Price, News, Quote & History - Yahoo! Finance Canada
AVITA Medical (OTCPK:AVHH.L) Stock Forecast & Analyst Predictions - simplywall.st
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Avita Medical Inc. Discloses CDI and Securities Statement for August 2026 - Kalkine
Avita Medical Issues 18,293 Restricted US Stock Units to Key Management Personnel - Kalkine
Avita Medical Issues 25,213 Unquoted Options Expiring August 2036 Under Employee Incentive Scheme - Kalkine
Avita Medical Issues 17,151 Common Stock Securities Following Multiple Option Conversions - Kalkine
Precision Trading with Avita Medical Inc. (RCEL) Risk Zones - Stock Traders Daily
564,952 Shares in Avita Medical Inc. $RCEL Bought by BlackRock Inc. - MarketBeat
RCEL stock gains on fresh price data while Avita Medical readies next steps - ad-hoc-news.de
Gross margin % of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – HAM:51KB - TradingView
AVITA Medical to Present at Lake Street and Morgan Stanley Healthcare Conferences in September 2026 - Kalkine
Net current asset value per share of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – HAM:51KB - TradingView
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference - Investing News Network
AVITA Medical to Showcase Leadership at Lake Street and Morgan Stanley Healthcare Conferences in September 2026 - Kalkine Media
A live webcast will carry AVITA Medical’s Sept. 16 conference discussion. - Stock Titan
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs Balance Sheet – HAM:51KB - TradingView
51KB Stock Price and Chart — HAM:51KB - TradingView
51KB Stock Price and Chart — HAM:51KB - TradingView
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference - Yahoo Finance
All You Need to Know About Avita Medical (RCEL) Rating Upgrade to Buy - Yahoo Finance
Avita Medical Inc.ADR Peer Comparison – Compare with Others - Value Research
Avita Medical Inc.ADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Avita Medical Is Maintained at Buy by Lake Street - Moomoo
Avita Medical Inc.ADR Key Financial Ratios – Valuation, Profitability & More - Value Research
RCEL | Avita Medical, Inc. Common FinancialsRevenue Breakdown - quiverquant.com
Why Is AVITA Medical (ASX: AVH) Stock Up Over 100% in a Month? PermeaDerm Study Results Fuel the Rally - Kalkine
AVITA Medical: Favorable Reimbursements For Skin Wound Care (NASDAQ:RCEL) - Seeking Alpha
AVITA Medical (RCEL) CFO boosts direct stake to 152,927 shares - stocktitan.net
RCEL Maintained by TD Cowen -- Price Target Raised to $14.00 - GuruFocus
TD Cowen raises Avita Medical stock price target on PermeaDerm data - Investing.com Canada
RCEL Maintained by BTIG -- Price Target Raised to $11.00 - GuruFocus
AVITA Medical (NASDAQ:RCEL) Raises Full-Year Guidance on Spray-On Skin Adoption - Kalkine Media
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. Allograft - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BTIG raises Avita Medical stock price target on positive trial data - Investing.com
BTIG raises Avita Medical stock price target on positive trial data - Investing.com Canada
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Raises Target Price to $14 - Moomoo
THREE HEALTHCARE STOCKS on radar - Kalkine
Avita Medical Inc. (NASDAQ:RCEL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AVITA Medical (ASX:AVH) Jumps 23.18% as Shares Extend a 67% One-Year Recovery - Kalkine
AVITA Medical (ASX:AVH) Soars 22.73% as Revenue Upgrade and Cash-Flow Target Reset the Conversation - Kalkine
AVITA Medical (ASX: AVH) Reports 70% Cost Advantage for PermeaDerm in Randomized Study - Kalkine
Avita Medical Says Clinical Study for Biosynthetic Wound Matrix Meets Primary Endpoint - marketscreener.com
AVITA Medical's PermeaDerm-I Study Reveals 70% Cost Savings Over Cadaveric Allograft with Equivalent Clinical Results - Kalkine Media
AVITA Medical Inc to Host Key Opinion Leader Webinar Transcript - GuruFocus
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Avita Medical Inc 주식 (RCEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Woody Joseph Fralin | Director |
Jun 09 '26 |
Buy |
4.19 |
10,000 |
41,900 |
102,761 |
| Woody Joseph Fralin | Director |
Jun 03 '26 |
Buy |
4.09 |
10,000 |
40,949 |
92,761 |
| Woody Joseph Fralin | Director |
Jun 02 '26 |
Buy |
4.19 |
10,000 |
41,936 |
20,000 |
| Woody Joseph Fralin | Director |
Jun 01 '26 |
Buy |
4.30 |
10,000 |
43,000 |
10,000 |
| O'Toole David D | CFO |
May 20 '26 |
Buy |
4.26 |
2,000 |
8,520 |
145,927 |
| O'Toole David D | CFO |
May 19 '26 |
Buy |
4.24 |
2,000 |
8,480 |
143,927 |
| O'Toole David D | CFO |
Feb 19 '26 |
Buy |
4.15 |
3,000 |
12,450 |
140,127 |
1.66%
4.48%
자본화:
|
볼륨(24시간):